Also known as: Association pour la recherche sur les Affections Malignes en Immunologie Sanguine
Highest phase reached
Phase 4
First clinical trial
Last known activity
Jan 1, 2013
No events for the selected filters.
Phase 4 (1 own, 0 via acquisition)
Studied for